Oct 2 |
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
Oct 1 |
Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
|
Oct 1 |
LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
|
Sep 30 |
Amgen must face lawsuit claiming it hid $10.7 billion tax bill
|
Sep 30 |
Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating
|
Sep 30 |
Prescription For Dividends: Why Amgen Is More Than Just A Safe Bet
|
Sep 29 |
Institutional investors may overlook Amgen Inc.'s (NASDAQ:AMGN) recent US$7.9b market cap drop as long-term gains remain positive
|
Sep 28 |
Amgen initiated with an Overweight at Cantor Fitzgerald
|
Sep 27 |
Regeneron Pharmaceuticals Suffers Worst Month in Two Years After Legal Setback
|
Sep 27 |
Cantor highly bullish on Amgen obesity drug, starts coverage at overweight
|